10-Year ASCVD Risk Calculator

What the pooled cohort equations estimate

The pooled cohort equations are the risk formula behind the 2013 ACC/AHA cholesterol guideline, published in Circulation by Goff and colleagues. They estimate the chance that a person who has never had a cardiovascular event will have one within the next 10 years. The guideline calls that outcome hard ASCVD, and it covers exactly four things: a first nonfatal heart attack, death from coronary heart disease, a nonfatal stroke, and death from a stroke.

That list is narrower than the phrase heart disease suggests. Angina, heart failure, a stent, a bypass operation and peripheral artery disease are not counted in the number this page produces. A person can hold a 6% score and still end up in a cardiology clinic with chest pain. The score answers one question: how likely is a first major event in the next decade?

The equations use nine facts about you: age, sex, race group, total cholesterol, HDL cholesterol, systolic blood pressure, whether you take blood pressure medicine, whether you smoke now, and whether you have diabetes. There are four versions of the formula, one for each combination of sex and race group, with different weights in each. Age carries more weight than anything else, which is why two people with identical lab numbers can land in different bands ten years apart in age.

Who should run these numbers, and who should not

The guideline that introduced the equations recommends a risk discussion for adults aged 40 to 75 who have never had a heart attack or stroke. That is the group the tool was built for, and it is the group where the score changes what happens next, because 7.5% is where the statin conversation usually starts.

People who should skip it:

• Anyone with known ASCVD. If you have had a heart attack, a stroke or a stent, you are already in the treat group. Your doctor will not wait on a percentage.
• Anyone with LDL cholesterol of 190 mg/dL or higher. That number alone is the diagnosis for treatment purposes, and the guideline handles it separately from the score.
• Adults under 40. The equations were derived from people aged 40 to 79, so a score at 35 is an extrapolation, not an estimate. Younger adults with diabetes, heavy family history or LDL above 190 should still see a doctor; the tool is the wrong instrument.
• Adults over 79. The same problem at the other end. The cohorts stopped at 79, and risk climbs so steeply with age that nearly everyone past that line scores high.

For everyone in the target group, the usual rhythm is to recheck the numbers every four to six years, or sooner after a big change in weight, blood pressure, medicines or smoking. The CDC counts heart disease as the leading cause of death in the United States, which is why the guideline pushed screening into routine visits rather than waiting for symptoms.

How the calculation works

Each input is converted to a natural log, multiplied by a weight, and added to a running total. Two of the terms mix age with cholesterol, so the effect of the same cholesterol number grows or shrinks with age. Blood pressure is scored differently depending on whether you take medicine for it, and smoking counts only if you smoke now, not if you quit years ago.

Here is the whole engine for a 58-year-old man with total cholesterol 220, HDL 42, systolic pressure 138, no blood pressure medicine, and current smoking:

• The weighted terms add up to 61.93.
• Subtract the cohort mean of 61.18 and you get 0.75.
• Raise e to that power and you get 2.12.
• Raise the baseline survival of 0.9144 to the 2.12 power, which gives 0.827.
• One minus 0.827 is 17.3%.

The calculator runs those five steps every time you change an input. If the man above had never smoked, the smoking terms would drop out, the total would fall, and the answer would drop to 10.4%. Seven points of risk, gone, from one checkbox.

Five profiles, five answers

The table below runs five different people through the same equations so you can see how much the inputs matter.

The 55-year-old at 41.6% deserves a comment. Diabetes, treated high blood pressure and smoking stack on top of each other, and the African American male equation weights blood pressure heavily. Roughly two of every five men with that profile would have a first event within ten years, which is why a doctor would talk about medicine at the first visit rather than after a diet trial.

How to read your result

The 2013 guideline splits scores into four bands, and the band matters more than the decimal point.

Two ways to make the number concrete. A score of 17.3% means that out of 1,000 men with that exact profile, about 173 would have a first heart attack or stroke within ten years, or about 1 in 6. A score of 5.3% is about 1 in 19, and a score of 0.6% is about 1 in 170.

Remember what the score is not. It is not your personal destiny; it is the average for a group of people who look the same on paper. It is not a lifetime forecast; a 45-year-old at 0.6% can still carry 30% or more lifetime risk, because lifetime risk and 10-year risk answer different questions. And it does not see your family history, your kidney function or your waistline, which is why doctors add risk enhancers on top of the score before deciding anything.

Where the equation is weakest

Being honest about the limits makes the number more useful, not less.

• Age dominates. A 70-year-old with excellent numbers can outscore a 45-year-old smoker. That is correct at the population level and misleading at the bedside, which is why younger people with strong family history get treated despite low scores.
• Race is a two-way switch. The equations only distinguish African American from White and everyone else. They underestimate risk in South Asian Americans and overestimate it in people of East Asian ancestry.
• The cohorts are old. The people who trained the model lived through the 1990s, before statins were widespread. Validation studies in modern populations have repeatedly found the equations run high, sometimes by a fifth or more.
• Smoking is a checkbox. The equation sees current yes or no, not three years ago or half a pack a day.

In 2023 the American Heart Association released a newer set of equations called PREVENT, which add kidney function, urine protein, HbA1c and social factors, and generally produce lower numbers. Many clinics and lab reports still print the pooled cohort score because the treatment thresholds are built around it. If your doctor quotes a number much lower than this page does, PREVENT is the likely reason.

What to bring to your next appointment

A printout of this score is most useful next to the raw inputs, so bring four things.

• The actual lipid panel, with total cholesterol and HDL, and the date it was drawn.
• Your average home blood pressure, not one office reading, plus the names of any pressure medicines.
• An honest answer on smoking, including anything you smoke occasionally.
• Family history: which relative, what event, and at what age.

Then ask two questions. First, does my score change what you would recommend today? Second, if the answer is a statin at 7.5% or higher, what would a coronary calcium scan show before I commit? The scan often costs between $100 and $400 without insurance, and a score of zero reclassifies roughly half of intermediate-risk patients into the low group, which changes the whole plan. The NIH heart, lung and blood institute keeps a plain-language guide to cholesterol numbers that pairs well with this page if you want a second reference before the visit.